Resources search

Fight AMR : save medicines for our children : call for action

ECUMENICAL PHARMACEUTICAL NETWORK (EPN)
2008

Expand view

This leaflet has been produced to raise awareness about antimicrobial resistance and possible areas of intervention including infection control, promoting effective diagnosis, improving prescribing practices and encouraging optimal use of antimicrobial agents. It is targeted at all the different groups of stakeholders who are in position to contribute to implementation of the containment actions that have been defined in the WHO Global Strategy for Containment of Antimicrobial Resistance

Good governance for medicines : assessment instrument

WORLD HEALTH ORGANIZATION (WHO)
2007

Expand view

This briefing describes an assessment instrument that can be used when carrying out a national assessment of transparency and vulnerability to corruption as part of the WHO's programme to promote good governance for medicines

Relevant health information for empowered citizens

HEALTH ACTION INTERNATIONAL (HAI)
2006

Expand view

Information is an integral part of healthcare: the need for patients to give informed consent is the basis of all care and treatment. For patients to be able to make informed choices they need information that is reliable, comparative and adapted to users, and that is not linked to advertising and drug promotion

Containing antimicrobial resistance

WORLD HEALTH ORGANIZATION (WHO)
April 2005

Expand view

The emergence of antimicrobial resistance is a natural phenomenon that follows use of antimicrobial drugs but it is being accelerated by inappropriate antimicrobial use. This leaflet considers various methods that can be used to help contain antimicrobial resistance

Pharmacovigilance : ensuring the safe use of medicines

WORLD HEALTH ORGANIZATION (WHO)
October 2004

Expand view

This leaflet looks at the need for pharmacovigilance to prevent or reduce the harm to patients caused by adverse effects of some medication. Pharmacovigilance is considered in terms of a national drugs policy, the regulation of medicines, clinical practice and disease control in public health programmes

How to develop and implement a national drug policy

WORLD HEALTH ORGANIZATION (WHO)
January 2003

Expand view

This leaflet outlines the steps to creating a national drugs policy. It sets out the key components, the selection process for essential medicines, affordability, financing options, supply systems, regulation and quality assurance, rational use, human resources development, and monitoring and evaluation

The selection of essential medicines

WORLD HEALTH ORGANIZATION (WHO)
June 2002

Expand view

Essential medicines are those that satisfy the priority health care needs of the population. This leaflet looks at the policy and relevance of the concept of essential medicines, how they can be selected, and how to implement a national list of essential medicines

Globalization, TRIPS and access to pharmaceuticals

WORLD HEALTH ORGANIZATION (WHO)
March 2001

Expand view

This leaflet looks at the impact on the health sector of global trade and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). It lists the articles of the agreement that have the greatest relevance to essential medicines and to the pharmaceutical industry

WHO medicines strategy : 2000-2003

WORLD HEALTH ORGANIZATION (WHO)
December 2000

Expand view

This strategy is the basis for coordinated action to bring essential medicines to where they are most urgently needed. Where public health services and insurance are inadequate, health care and medicine costs mean that serious illness is a major reason why poor populations remain trapped in poverty

E-bulletin

Source e-bulletin on Disability and Inclusion

Subscribe to updates